Feb 24 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- HY UNDERLYING EBITDA $39.9M, DOWN 16%
- HY REPORTED REVENUE $208.8 MILLION VERSUS $227.2 MILLION
- Forums
- ASX - By Stock
- News: MYX Mayne Pharma Group Says HY Underlying EBITDA Down 16%
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.00

Feb 24 (Reuters) - Mayne Pharma Group Ltd (MYX) : HY UNDERLYING...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
0.010(0.20%) |
Mkt cap ! $407.8M |
Open | High | Low | Value | Volume |
$4.98 | $5.03 | $4.98 | $495.1K | 98.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 6896 | $5.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.01 | 2503 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 8871 | 5.000 |
3 | 13215 | 4.990 |
9 | 27771 | 4.980 |
6 | 20955 | 4.970 |
3 | 6016 | 4.960 |
Price($) | Vol. | No. |
---|---|---|
5.020 | 3147 | 16 |
5.030 | 35705 | 10 |
5.040 | 1387 | 3 |
5.050 | 1632 | 3 |
5.060 | 1016 | 2 |
Last trade - 15.44pm 11/08/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online